332113-62-9

Upstream product

• 53913-96-5 tert-butyl 2-(bromomethyl)acrylate 
• 118636-74-1 ((R)-1-(((benzyloxy)carbonyl)amino)-2-phenylethyl)phosphinic acid 

Downstream Products

• 332113-71-0 [(R),(S)]-(1-benzyloxycarbonylamino-2-phenylethyl){2-[1-carbamoyl-2-(1H-indol-3-yl)ethylcarbamoyl]allyl}phosphinic acid 
• 332113-64-1 (R)-2-[(1-benzyloxycarbonylamino-2-phenylethyl)hydroxyphosphinoylmethyl]acrylic acid 
• 656823-10-8 [(R),(R,S),(S)]-(1-benzyloxycarbonylamino-2-phenylethyl)-{3-(4-bromo-2-trifluoromethoxyphenylsulfanyl)-2-[1-carbamoyl-2-(1H-indol-3-yl)ethylcarbamoyl]propyl}phosphinic acid 

Relevant academic research and scientific papers

Evaluation of P1'-Diversified Phosphinic Peptides Leads to the Development of Highly Selective Inhibitors of MMP-11

Phosphinic peptides were previously reported to be potent inhibitors of several matrixins (MMPs). To identify more selective inhibitors of MMP-11, a matrixin overexpressed in breast cancer, a series of phosphinic pseudopeptides bearing a variety of P

Convenient synthesis and diversification of dehydroalaninyl phosphinic peptide analogues.

[structure: see text]. Dehydroalaninyl phosphinic dipeptide analogues were synthesized, via an efficient tandem Arbuzov addition/allylic rearrangement, in high yields. The susceptibility of the conjugate system to 1,4 nucleophilic additions was investigat